Rimonabant
EFC6648
Phase 3 small_molecule terminated
Quick answer
Rimonabant for Obesity is a Phase 3 program (small_molecule) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pasteur
- Indication
- Obesity
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated